Pro Medicus | PME

Stock Price
298.45
Daily Change
0.22 0.07%
Monthly
-2.08%
Yearly
89.45%
Q3 Forecast
296.62

Peers Price Chg Day Year Date
Alcidion 0.09 -0.002 -2.20% 39.06% Sep/08
Appen 0.87 -0.01 -0.57% -30.12% Sep/08
Nanosonics 3.94 -0.08 -1.99% 10.36% Sep/08
PainChek 0.04 -0.001 -2.27% 30.30% Sep/08
Somnomed 0.70 -0.01 -1.41% 72.84% Sep/08

Indexes Price Day Year Date
Australia All Ordinaries 9116 -24.20 -0.26% 11.28% Sep/08
ASX200 8794 -77.40 -0.87% 10.09% Sep/08

Pro Medicus Ltd traded at 298.06 this Monday September 8th, decreasing 0.17 or 0.06 percent since the previous trading session. Looking back, over the last four weeks, Pro Medicus lost 2.20 percent. Over the last 12 months, its price rose by 89.21 percent. Looking ahead, we forecast Pro Medicus Ltd to be priced at 296.62 by the end of this quarter and at 291.84 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.